Drugs News and Research

RSS

Focus on treating just the heart jeopardizes health of elderly in cardiac intensive care units

Medical professionals have announced the need to change treatment of elderly patients in cardiac intensive care units.

9 Dec 2019

Computer betting game can help predict the likelihood of opioid reuse

A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.

8 Dec 2019

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients' bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

8 Dec 2019

New startup aims to prevent reperfusion-related organ damage after liver transplant

Roughly 65 years ago, the first human organ transplant was successfully performed. A decade later, heart and liver transplants became possible. Now, a startup founded by researchers from the Medical University of South Carolina and elsewhere hopes to bring about the next major breakthrough.

8 Dec 2019

New technique holds promise in cancer research and science studies

A new technique reported this week in Science overcomes several limitations of typical high-throughput chemical screens conducted on cell samples. Such screens are commonly used to try to discover new cancer drugs, and in many other biomedical applications.

8 Dec 2019

Innovative consortium will provide access to newest clinical trials and medical breakthroughs

New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

8 Dec 2019

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

8 Dec 2019

Nanosize container can slip inside cells and deliver medicines, gene therapies

Scientists at Johns Hopkins Medicine report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size - even hefty ones attached to the gene-editing tool called CRISPR.

6 Dec 2019

New compounds with herbicidal potential isolated from marine-derived fungus

Scientists of Far Eastern Federal University and the G.B. Elyakov Pacific Institute of Bioorganic Chemistry together with German colleagues spotted six new and three already known biologically active compounds in a new strain of the fungus Penicillium piltunense first time isolated.

6 Dec 2019

New tool can rapidly reveal unintended changes made by CRISPR-directed gene editing

Amidst rising hopes for using CRISPR gene editing tools to repair deadly mutations linked to conditions like cystic fibrosis and sickle cell disease, a new study in the Nature journal Communications Biology describes a new innovation that could accelerate this work by rapidly revealing unintended and potentially harmful changes introduced by a gene editing process.

6 Dec 2019

Researchers identify a missed opportunity in the treatment of ER+ breast cancers

In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most common cause of death from cancer among Hispanic women and the second most common among all other women, after lung cancer.

6 Dec 2019

Researchers discover potent next generation of drugs to fight leukemia and lymphoma

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children.

6 Dec 2019

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

6 Dec 2019

Kanazawa University researchers describe genetic typing of Pseudomonas putida

Pseudomonas putida is a bacterium occuring in soil, aquatic environments and plants. Although the virulence of Pseudomonas p. -- the ability of the bacterium to infect its host and inflict a disease -- is considered to be low, infection in severely ill patients can be lethal. P. putida strains (also called isolates) have been found in hospitals, e.g. in urine, blood or wound discharge from patients, and such clinical isolates have been found to display resistance to drugs.

6 Dec 2019

Genetically engineered living hydrogel material facilitates intestinal wound healing

About 1.6 million people in the US alone currently have lifelong and incurable Inflammatory Bowel Disease (IBD) including Crohn's disease and ulcerative colitis, and 70,000 new cases are diagnosed in the USA each year.

6 Dec 2019

Patient-induced trauma: Hospitals learn to defuse violence

When Mary Prehoden gets dressed for work every morning, her eyes lock on the bite-shaped scar on her chest.

6 Dec 2019

Website errors raise calls for Medicare to be flexible with seniors’ enrollment

Saturday is the deadline for most people with Medicare coverage to sign up for private drug and medical plans for next year.

6 Dec 2019

Evergreen Life spearheads the drive for everyone to have access to personal health data

Recent media reports have focused on the prospect that US businesses may want to buy patient data from the NHS.

From Evergreen Life 6 Dec 2019

Scientists test repurposed drugs for treatment of rare eye condition

Fight for Sight is funding scientists from the University of Aberdeen to test two repurposed drugs for the treatment of the rare eye condition aniridia, which causes blindness.

6 Dec 2019

US pharmaceutical industry continues to shine according to CPhI 2019 Annual Report

The US pharmaceutical industry continues to lead its global peers in terms of innovation and competitiveness, while still ranking high in overall growth potential despite its mature status, according to the results of a survey of 350 global pharmaceutical industry executives published as part of the recently released CPhI 2019 Annual Report.

From LabVantage Solutions 6 Dec 2019

Drugs News and Research

Focus on treating just the heart jeopardizes health of elderly in cardiac intensive care units

Computer betting game can help predict the likelihood of opioid reuse

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

New startup aims to prevent reperfusion-related organ damage after liver transplant

New technique holds promise in cancer research and science studies

Innovative consortium will provide access to newest clinical trials and medical breakthroughs

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

Nanosize container can slip inside cells and deliver medicines, gene therapies

New compounds with herbicidal potential isolated from marine-derived fungus

New tool can rapidly reveal unintended changes made by CRISPR-directed gene editing

Researchers identify a missed opportunity in the treatment of ER+ breast cancers

Researchers discover potent next generation of drugs to fight leukemia and lymphoma

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

Kanazawa University researchers describe genetic typing of Pseudomonas putida

Genetically engineered living hydrogel material facilitates intestinal wound healing

Patient-induced trauma: Hospitals learn to defuse violence

Website errors raise calls for Medicare to be flexible with seniors’ enrollment

Evergreen Life spearheads the drive for everyone to have access to personal health data

Scientists test repurposed drugs for treatment of rare eye condition

US pharmaceutical industry continues to shine according to CPhI 2019 Annual Report

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News